Goto K, Goto Y, Kubo T, Ninomiya K, et al. Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial. J Clin Oncol 2023 Sep 11:JCO2301361. doi: 10.1200/JCO.23.01361.
PMID: 37694347